 CALABASAS, Calif., Oct. 13, 2021 GLOBE NEWSWIRE -- MusclePharm Corporation OTCMKTS: MSLP, a global provider of leading sports nutrition lifestyle branded nutritional supplements, today announced that it has entered into definitive agreements with accredited institutional investors for gross proceeds of approximately 7,050,000. The definitive agreements provide for the private placement of 14 Original Issue Discount Senior Secured Notes Notes in the aggregate principal amount of approximately 8.2 million. The principal amount of the Notes will be due on April 13, 2022. In addition, the Company has agreed to issue to the investors unregistered warrants for the purchase of 17,355,700 shares of common stock. Each warrant entitles the holder to purchase one share of common stock at an initial exercise price of 0.78 for a period of five years from the date of issuance. 